Edgewise Therapeutics, Inc. (EWTX) Insider Ownership

Data spanning the past 90 days through February 19, 2026 reveals that Edgewise Therapeutics's three principal insider shareholders consist of TenPercentOwner Holdings A/S Novo (6.07Mn shares), Director Peter A. Thompson (443.79K shares), Director Advisors Llc Orbimed (443.79K shares).

• A detailed ownership breakdown for Edgewise Therapeutics is not available at this time.
• As of February 19, 2026, Edgewise Therapeutics's insider ownership stands at 11.88% of outstanding equity, representing about 11.82Mn shares within the total 99.52Mn shares outstanding.
• During the 90-day period through February 19, 2026, Edgewise Therapeutics experienced a 0.10% increased in insider ownership, with total insider shares growing from 11.81Mn to 11.82Mn.
• As of February 19, 2026, Director Badreddin Edris recorded the highest insider purchase activity at Edgewise Therapeutics, accumulating 115.47K shares during the past 90 days.
• As of February 19, 2026, Director Badreddin Edris executed the most significant insider divestiture at Edgewise Therapeutics, disposing of 115.47K shares over the last 90-day period.